logo
Plus   Neg
Share
Email

Revance Therapeutics (RVNC) Pulled Back After CFO Resigned

Revance Therapeutics (RVNC) announced Tuesday morning that Lauren Silvernail has resigned as its Chief Financial Officer and Chief Business Officer.

Revance Therapeutics declined sharply during the first hour of trade Tuesday and closed down by 3.17 at $27.97. The stock fell to nearly a 3-week low.

For comments and feedback contact: editorial@rttnews.com

Business News

RELATED NEWS
Follow RTT